I’m happy to share that I’m starting a new position as Scientific co-founder LASEREDD Therapeutics" Ross

Ines Liebscher, Ross Cheloha and Silvio Gutkind.

Canonical chemokine receptors as scavenging “decoys” Shivani Sachdev, Brendan Creemer, Thomas Gardella, and Ross Cheloha for their work on Highly biased agonism for GPCR ligands via nanobody tethering Elk Kossatz,

Vasilis Panagiotopoulos, Robin du Preez, Michail Papadourakis, Konstantinos Tsianakas, Robert P Millar, Ross

and Immunology Evolutionary diversity of CXCL16-CXCR6: Convergent substitutions and recurrent gene loss We establish recurrent CXCR6 gene loss in 10 out of 36 bird orders, including Galliformes and Passeriformes Notably, single-cell RNA sequencing of the lung shows a drop in TRM cells in species with CXCR6 loss, The concurrent loss of ITGAE, CXCL16, and CXCR6 in chickens may have altered CD8 TRM cell abundance,

Pathophysiology Date & Time Friday, November 3rd / 9:45 AM Abstract Coming Soon Authors and Affiliations Gross About Joshua Gross "I am a neuropharmacologist interested in exploiting GPCR biased signaling to design pharmacotherapies that improve efficacy and minimize side effects for diet-induced metabolic diseases. " Josh Gross